miércoles, 9 de octubre de 2013

i-Gel

I-gel Bibliografía


BIBLIOGRAPHY
i-gel bibliography Volume 1, Issue 2 September 2013

Published studies, case reports and correspondence .Welcome to the second edition of the Intersurgical® i-gel® bibliography, which now features even more studies, case reports and correspondence relating to this innovative airway management device, up to March 2013.
The i-gel® is a second generation supraglottic airway, made of a medical grade thermoplastic elastomer, designed to create a non-inflatable anatomical seal of the pharyngeal, laryngeal and perilaryngeal structures. An integrated gastric channel provides an early warning of regurgitation, facilitates venting of gas from the stomach and allows for the passing of a suction tube to empty the stomach contents. The device also includes a buccal cavity stabiliser to provide vertical streng......
http://media.intersurgical.com/global/documents/i-gel_bibliography_2.pdf?dm_i=1QMT,1S4Z4,BFYGL7,6PCEY,1




Comparación del rendimiento clínico de I-gel con ML proseal

Comparison of clinical performance of the I-gel with LMA proseal.
Chauhan G, Nayar P, Seth A, Gupta K, Panwar M, Agrawal N.
Department of Anesthesia and Intensive Care, Safdarjang Hospital, New Delhi, India.
J Anaesthesiol Clin Pharmacol. 2013 Jan;29(1):56-60. doi: 10.4103/0970-9185.105798.

Abstract
AIM:To compare insertion characteristics of 2 different supraglottic devices [I-gel and Proseal laryngeal mask airway (PLMA)] and to observe any associated complications. STUDY DESIGN: This prospective, randomized study was conducted in 80 patients [Group I - I-gel insertion (n = 40) and Group P - LMA Proseal insertion (n =40)] of ASA grades I/II, of either sex in the age group 18-65 years. Both groups were compared with respect to ease of insertion, insertion attempts, fiberoptic assessment, airway sealing pressure, ease of gastric tube placement, and other complications. MATERIALS AND METHODS: All patients were asked to fast overnight. Patients were given alprazolam 0.25 mg orally at 10 p.m. the night before surgery and again 2 hours prior to surgery with 1-2 sips of water. Glycopyrrolate 0.2 mg, metoclopramide 10 mg, and ranitidine 50 mg were administered intravenously to the patients 45 minutes prior to the surgery. Once adequate depth of anesthesia was achieved either of the 2 devices, selected using a random computerized table, was inserted by an experienced anesthesiologist. In group I, I-gel was inserted and in patients of group P, PLMA was inserted. STATISTICAL ANALYSIS: Student t-test and Mann-Whitney test were employed to compare the means; for categorical variables, Chi-square test was used. RESULT: Mean insertion time for the I-gel (11.12 ± 1.814 sec) was significantly lower than that of the PLMA (15.13 ± 2.91 sec) (P = 0.001). I-gel was easier to insert with a better anatomic fit. Mean airway sealing pressure in the PLMA group (29.55 ± 3.53 cm H2O) was significantly higher than in theI-gel group (26.73 ± 2.52 cm H2O; P = 0.001). Ease of gastric tube insertion was significantly higher in the I-gel group (P = 0.001). Incidence of blood staining of the device, sore throat and dysphagia were observed more in PLMA group. No other complications were observed in either of the groups.
KEYWORDS:Airway sealing, I-gel, cuff pressure, fiberoptic, insertion, leak, proseal laryngeal mask airway

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590543/




Comparación randomizada de la efectividad de ML supreme, i-gel y el manejo actual de la vía aérea en el paro cardiaco prehospitalario (REVIVE-Airways). Protocolo de investigación del estudio de viabilidad
Randomised comparison of the effectiveness of the laryngeal mask airway supreme, i-gel and current practice in the initial airway management of prehospital cardiac arrest (REVIVE-Airways): a feasibility study research protocol.
Benger JR, Voss S, Coates D, Greenwood R, Nolan J, Rawstorne S, Rhys M, Thomas M.
Academic Department of Emergency Care, The University Hospitals NHS Foundation Trust, Bristol, UK.
BMJ Open. 2013 Feb 13;3(2). pii: e002467. doi: 10.1136/bmjopen-2012-002467. Print 2013
Abstract
INTRODUCTION: Effective cardiopulmonary resuscitation with appropriate airway management improves outcomes following out-of-hospital cardiac arrest (OHCA). Historically, tracheal intubation has been accepted as the optimal form of OHCA airway management in the UK. The Joint Royal Colleges Ambulance Liaison Committee recently concluded that newer supraglottic airway devices (SADs) are safe and effective devices for hospital procedures and that their use in OHCA should be investigated. This study will address an identified gap in current knowledge by assessing whether it is feasible to use a cluster randomised design to compare SADs with current practice, and also to each other, during OHCA. METHODS AND ANALYSIS: The primary objective of this study is to assess the feasibility of a cluster randomised trial to compare the ventilation success of two newer SADs: the i-gel and the laryngeal mask airway supreme to usual practice during the initial airway management of OHCA. The secondary objectives are to collect data on ventilation success, further airway interventions required, loss of a previously established airway during transport, airway management on arrival at hospital (or termination of the resuscitation attempt), initial resuscitation success, survival to intensive care admission, survival to hospital discharge and patient outcome at 3 months. Ambulance paramedics will be randomly allocated to one of the three methods of airway management. Adults in medical OHCA attended by a trial paramedic will be eligible for the study. ETHICS AND DISSEMINATION: Approval for the study has been obtained from a National Health Service Research Ethics Committee with authority to review proposals for trials of a medical device in incapacitated adults. The results will be made publicly available on an open access website, and we will publish the findings in appropriate journals and present them at national and international conferences relevant to the subject field.
TRIAL REGISTRATION:
ISRCTN: 18528625.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586153/pdf/bmjopen-2012-002467.pdf


Atentamente
Anestesiología y Medicina del Dolor
www.anestesia-dolor.org

Publicar un comentario